Coherus BioSciences, Inc. Business Operations Contracts & Agreements
9 Contracts & Agreements
- Distribution Agreements (1 contract)
- Indemnification Agreements (1)
- Sales Agreements (3)
- Services Agreements (2)
- Settlement Agreements (2)
- Amendment No. 2 to Sales Agreement between Coherus BioSciences, Inc. and Cowen and Company, LLC dated September 11, 2023 (Filed With SEC on November 6, 2023)
- Settlement and License Agreement among Coherus BioSciences, Inc., AbbVie Inc. and AbbVie Biotechnology Ltd dated January 24, 2019 (Filed With SEC on November 6, 2023)
- Amendment No. 1 to Sales Agreement between Coherus BioSciences, Inc. and Cowen and Company, LLC, dated May 15, 2023 (Filed With SEC on August 2, 2023)
- Confidential Litigation Settlement Agreement and Release, dated as of April 30, 2019 between Amgen Inc. and Amgen USA Inc. (collectively Amgen), and Coherus BioSciences Inc (Filed With SEC on August 5, 2019)
- Letter Agreement to Master Service Agreement, dated as of September 6, 2017, by and between Medpace, Inc. and Coherus BioSciences, Inc (Filed With SEC on November 6, 2017)
- COHERUS BIOSCIENCES, INC. $100,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on October 28, 2016)
- MASTER SERVICES AGREEMENT (Filed With SEC on May 11, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on October 24, 2014)
- DISTRIBUTION AGREEMENT (Filed With SEC on September 25, 2014)
